메뉴 건너뛰기




Volumn 4, Issue 2, 2016, Pages 107-115

Correction to Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study (The Lancet Respiratory Medicine (2016) 4(2) (107–115) (S2213260015005457) (10.1016/S2213-2600(15)00545-7));Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-years with cystic fibrosis and a CFTR gating mutation (KIWI): An open-label, single-arm study

(54)  Davies, Jane C a,b   Cunningham, Steve c   Harris, William T d   Lapey, Allen e   Regelmann, Warren E f   Sawicki, Gregory S g   Southern, Kevin W h   Robertson, Sarah i   Green, Yulia i   Cooke, Jon i   Rosenfeld, Margaret j   Bufi, Janine j   Sharon McNamara, j   Reeves, Ginger j   Hathorne, Heather j   Brand, Katie j   Harris, William d   Spahr, Jonathan d   Hartigan, Elizabeth k   Noren, Brooke k   more..


Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; IVACAFTOR; AMINOPHENOL DERIVATIVE; CFTR PROTEIN, HUMAN; CHLORIDE CHANNEL STIMULATING AGENT; QUINOLONE DERIVATIVE;

EID: 84958107856     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(16)30386-1     Document Type: Erratum
Times cited : (288)

References (27)
  • 1
    • 73249114731 scopus 로고    scopus 로고
    • Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
    • Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA 2009, 106:18825-18830.
    • (2009) Proc Natl Acad Sci USA , vol.106 , pp. 18825-18830
    • Van Goor, F.1    Hadida, S.2    Grootenhuis, P.D.3
  • 2
    • 84862776940 scopus 로고    scopus 로고
    • Ivacaftor potentiation of multiple CFTR channels with gating mutations
    • Yu H, Burton B, Huang CJ, et al. Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros 2012, 11:237-245.
    • (2012) J Cyst Fibros , vol.11 , pp. 237-245
    • Yu, H.1    Burton, B.2    Huang, C.J.3
  • 3
    • 0003625836 scopus 로고    scopus 로고
    • Cystic Fibrosis Foundation, Bethesda, MD
    • Patient Registry 2012 Annual Data Report 2013, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation, Bethesda, MD.
    • (2013) Patient Registry 2012 Annual Data Report
  • 4
    • 84878970875 scopus 로고    scopus 로고
    • Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation
    • Davies JC, Wainwright CE, Canny GJ, et al. Efficacy and safety of ivacaftor in patients aged 6 to 11 years with cystic fibrosis with a G551D mutation. Am J Respir Crit Care Med 2013, 187:1219-1225.
    • (2013) Am J Respir Crit Care Med , vol.187 , pp. 1219-1225
    • Davies, J.C.1    Wainwright, C.E.2    Canny, G.J.3
  • 5
    • 80455162465 scopus 로고    scopus 로고
    • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation
    • Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011, 365:1663-1672.
    • (2011) N Engl J Med , vol.365 , pp. 1663-1672
    • Ramsey, B.W.1    Davies, J.2    McElvaney, N.G.3
  • 6
    • 84911493956 scopus 로고    scopus 로고
    • Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
    • De Boeck K, Munck A, Walker S, et al. Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. J Cyst Fibros 2014, 13:674-680.
    • (2014) J Cyst Fibros , vol.13 , pp. 674-680
    • De Boeck, K.1    Munck, A.2    Walker, S.3
  • 7
    • 77953378283 scopus 로고    scopus 로고
    • Pathophysiology and therapeutic targets
    • Moss R Pathophysiology and therapeutic targets. Johns Hopkins Adv Studies Med 2010, 10:9-13.
    • (2010) Johns Hopkins Adv Studies Med , vol.10 , pp. 9-13
    • Moss, R.1
  • 8
    • 0029121023 scopus 로고
    • Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis
    • Couper RT, Corey M, Durie PR, Forstner GG, Moore DJ Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosis. J Pediatr 1995, 127:408-413.
    • (1995) J Pediatr , vol.127 , pp. 408-413
    • Couper, R.T.1    Corey, M.2    Durie, P.R.3    Forstner, G.G.4    Moore, D.J.5
  • 9
    • 0018421282 scopus 로고
    • Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants
    • Imrie JR, Fagan DG, Sturgess JM Quantitative evaluation of the development of the exocrine pancreas in cystic fibrosis and control infants. Am J Pathol 1979, 95:697-708.
    • (1979) Am J Pathol , vol.95 , pp. 697-708
    • Imrie, J.R.1    Fagan, D.G.2    Sturgess, J.M.3
  • 10
    • 70349831005 scopus 로고    scopus 로고
    • Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening
    • Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009, 155:623-628.
    • (2009) J Pediatr , vol.155 , pp. 623-628
    • Stick, S.M.1    Brennan, S.2    Murray, C.3
  • 11
    • 84922259983 scopus 로고    scopus 로고
    • Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy
    • Li L, Somerset S Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig Liver Dis 2014, 46:865-874.
    • (2014) Dig Liver Dis , vol.46 , pp. 865-874
    • Li, L.1    Somerset, S.2
  • 12
    • 0036299705 scopus 로고    scopus 로고
    • Nutrition in patients with cystic fibrosis: a European Consensus
    • Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002, 1:51-75.
    • (2002) J Cyst Fibros , vol.1 , pp. 51-75
    • Sinaasappel, M.1    Stern, M.2    Littlewood, J.3
  • 13
    • 84884683771 scopus 로고    scopus 로고
    • Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants
    • Nguyen TT, Thia LP, Hoo AF, et al. Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014, 69:910-917.
    • (2014) Thorax , vol.69 , pp. 910-917
    • Nguyen, T.T.1    Thia, L.P.2    Hoo, A.F.3
  • 14
    • 84861892411 scopus 로고    scopus 로고
    • Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial
    • Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012, 307:2269-2277.
    • (2012) JAMA , vol.307 , pp. 2269-2277
    • Rosenfeld, M.1    Ratjen, F.2    Brumback, L.3
  • 15
    • 47049115524 scopus 로고    scopus 로고
    • Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
    • Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153:S4-S14.
    • (2008) J Pediatr , vol.153 , pp. S4-S14
    • Farrell, P.M.1    Rosenstein, B.J.2    White, T.B.3
  • 16
    • 84976585919 scopus 로고    scopus 로고
    • (accessed Dec 2).
    • Kalydeco summary of product characteristics European Medicines Agency, (accessed Dec 2, 2015). http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002494/WC500130696.pdf.
    • (2015) Kalydeco summary of product characteristics
  • 17
    • 12744281454 scopus 로고    scopus 로고
    • (accessed Dec 2).
    • Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 National Cancer Institute, Cancer Therapy Evaluation ProgramCancer Therapy Evaluation Program, (accessed Dec 2, 2015). http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm.
    • (2015) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0
  • 18
    • 34250190592 scopus 로고    scopus 로고
    • An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children
    • Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007, 175:1304-1345.
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 1304-1345
    • Beydon, N.1    Davis, S.D.2    Lombardi, E.3
  • 22
    • 81855167481 scopus 로고    scopus 로고
    • Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl(-channels and luminal anion exchangers
    • Pallagi P, Venglovecz V, Rakonczay Z, et al. Trypsin reduces pancreatic ductal bicarbonate secretion by inhibiting CFTR Cl(-channels and luminal anion exchangers. Gastroenterology 2011, 141:2228-2239.
    • (2011) Gastroenterology , vol.141 , pp. 2228-2239
    • Pallagi, P.1    Venglovecz, V.2    Rakonczay, Z.3
  • 23
    • 0034757380 scopus 로고    scopus 로고
    • Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?
    • Arets HG, Brackel HJ, van der Ent CK Forced expiratory manoeuvres in children: do they meet ATS and ERS criteria for spirometry?. Eur Respir J 2001, 18:655-660.
    • (2001) Eur Respir J , vol.18 , pp. 655-660
    • Arets, H.G.1    Brackel, H.J.2    van der Ent, C.K.3
  • 24
    • 84861226870 scopus 로고    scopus 로고
    • Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting
    • Kerby GS, Rosenfeld M, Ren CL, et al. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol 2012, 47:597-605.
    • (2012) Pediatr Pulmonol , vol.47 , pp. 597-605
    • Kerby, G.S.1    Rosenfeld, M.2    Ren, C.L.3
  • 25
    • 12744277962 scopus 로고    scopus 로고
    • Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis
    • Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005, 171:249-256.
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 249-256
    • Aurora, P.1    Bush, A.2    Gustafsson, P.3
  • 26
    • 67349175293 scopus 로고    scopus 로고
    • Lung clearance index in the assessment of airways disease
    • Horsley A Lung clearance index in the assessment of airways disease. Respir Med 2009, 103:793-799.
    • (2009) Respir Med , vol.103 , pp. 793-799
    • Horsley, A.1
  • 27
    • 9644259076 scopus 로고    scopus 로고
    • Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis
    • Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004, 59:1068-1073.
    • (2004) Thorax , vol.59 , pp. 1068-1073
    • Aurora, P.1    Gustafsson, P.2    Bush, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.